ZA200104616B - Diazepinoindoles for the treatment of chronic obstructive pulmonary disease. - Google Patents

Diazepinoindoles for the treatment of chronic obstructive pulmonary disease.

Info

Publication number
ZA200104616B
ZA200104616B ZA200104616A ZA200104616A ZA200104616B ZA 200104616 B ZA200104616 B ZA 200104616B ZA 200104616 A ZA200104616 A ZA 200104616A ZA 200104616 A ZA200104616 A ZA 200104616A ZA 200104616 B ZA200104616 B ZA 200104616B
Authority
ZA
South Africa
Prior art keywords
diazepinoindoles
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
ZA200104616A
Other languages
English (en)
Inventor
Annette Doherty
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200104616B publication Critical patent/ZA200104616B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200104616A 2000-06-09 2001-06-06 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease. ZA200104616B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
ZA200104616B true ZA200104616B (en) 2002-10-30

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104616A ZA200104616B (en) 2000-06-09 2001-06-06 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease.

Country Status (19)

Country Link
US (1) US6544983B2 (ru)
EP (1) EP1161949A1 (ru)
JP (1) JP2002138090A (ru)
KR (1) KR20010111457A (ru)
CN (1) CN1345725A (ru)
AR (1) AR030291A1 (ru)
AU (1) AU5181301A (ru)
BR (1) BR0102289A (ru)
CA (1) CA2347337A1 (ru)
CZ (1) CZ20011999A3 (ru)
EA (1) EA200100515A3 (ru)
HU (1) HUP0102388A3 (ru)
IL (1) IL143636A0 (ru)
MX (1) MXPA01005726A (ru)
NO (1) NO20012831L (ru)
NZ (1) NZ512222A (ru)
PL (1) PL347922A1 (ru)
SK (1) SK7832001A3 (ru)
ZA (1) ZA200104616B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
ES2378374T3 (es) * 2003-11-20 2012-04-11 Astellas Pharma Inc. Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
KR20090045233A (ko) 2006-07-10 2009-05-07 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
CA2711865A1 (en) 2008-01-11 2009-07-16 Astellas Pharma Inc. A pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN104968348B (zh) * 2012-05-22 2018-04-17 Paion英国有限公司 包含短效苯二氮杂*类化合物的组合物
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
NO20012831D0 (no) 2001-06-08
EA200100515A3 (ru) 2002-06-27
CA2347337A1 (en) 2001-12-09
US6544983B2 (en) 2003-04-08
IL143636A0 (en) 2002-04-21
CN1345725A (zh) 2002-04-24
PL347922A1 (en) 2001-12-17
EA200100515A2 (ru) 2001-12-24
BR0102289A (pt) 2002-03-12
CZ20011999A3 (cs) 2002-04-17
AU5181301A (en) 2001-12-13
KR20010111457A (ko) 2001-12-19
HUP0102388A2 (hu) 2002-04-29
NZ512222A (en) 2002-10-25
MXPA01005726A (es) 2003-08-20
HU0102388D0 (en) 2001-08-28
SK7832001A3 (en) 2002-05-09
HUP0102388A3 (en) 2004-11-29
AR030291A1 (es) 2003-08-20
US20020010175A1 (en) 2002-01-24
NO20012831L (no) 2001-12-10
JP2002138090A (ja) 2002-05-14
EP1161949A1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
HK1062408A1 (en) Remedies for infant chronic arthritis-relating diseases
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
ZA200104616B (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease.
EP1429775A4 (en) METHOD FOR THE TREATMENT OF LUNG DISEASES
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
PL369402A1 (en) Use for the treatment of gastroesophageal reflux disease
MXPA03003032A (es) Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos.
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
GB0105694D0 (en) Online transaction ledger
AU4335901A (en) Novel therapeutic treatment of chronic obstructive pulmonary disease
GB0029524D0 (en) Disease treatment
ZA200205835B (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.
GB0128628D0 (en) Disease treatment
HK1044884A1 (zh) 使用二氮染酮吲(diazepinoindoles)治療慢性阻塞性肺部疾病
IL146815A0 (en) Method for treating chronic obstructive pulmonary disease
AU3582101A (en) The treatment of functional gastrointestinal disorders
ZA200308844B (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
SI1257254T1 (sl) Farmacevtske oblike, ki vsebujejo antiholinergicno zdravilo za zdravljenje kronicne obstruktivne bolezni pljuc
GB0004998D0 (en) The treatment of functional gastrointestinal disorders
AU2001243359A1 (en) Novel therapeutic treatment of chronic obstructive pulmonary disease